Supplementary Table 1 from An Insertion/Deletion Polymorphism within RERT-lncRNA Modulates Hepatocellular Carcinoma Risk

Zhansheng Zhu,Xueren Gao,Yan He,Hua Zhao,Qiang Yu,Deke Jiang,Pingzhao Zhang,Xiaopin Ma,Huixing Huang,Dong Dong,Jiao Wan,Zhenyong Gu,Xinghong Jiang,Long Yu,Yuzhen Gao

DOI: https://doi.org/10.1158/0008-5472.22392306.v1

2023-01-01

Abstract:PDF file - 46K, Primers sequences used in this study

What problem does this paper attempt to address?

Supplementary Figure 2 from An Insertion/Deletion Polymorphism within RERT-lncRNA Modulates Hepatocellular Carcinoma Risk

Zhansheng Zhu,Xueren Gao,Yan He,Hua Zhao,Qiang Yu,Deke Jiang,Pingzhao Zhang,Xiaopin Ma,Huixing Huang,Dong Dong,Jiao Wan,Zhenyong Gu,Xinghong Jiang,Long Yu,Yuzhen Gao

DOI: https://doi.org/10.1158/0008-5472.22392321

2023-01-01

Abstract:PDF file - 68K, Example sequencing and genotyping output for rs10680577
Association Between the LINC00673 Rs11655237 C> T Polymorphisms with Cancer Risk in the Chinese Population: A Meta-Analysis

Hongyu Zhang,Baixiu Wu,Ka Liang,Liuhua Ke,Xingxuan Ma,Changliu Luo,Yong He

DOI: https://doi.org/10.1097/md.0000000000030353

IF: 1.6

2022-01-01

Medicine

Abstract:The present study aimed to conduct a meta-analysis of previously published studies in order to clarify the association of long noncoding RNA (lncRNAs) LINC00673 rs11655237 C> T polymorphism with cancer risk.Systematic review and meta-analysis.Electronic databases of PubMed, EMBASE, Web of Science, Cochrane Library, Chinese National Knowledge Infrastructure, and Wanfang Database were used to search relevant studies. Studies published up to October 20, 2019 were included. The included studies were assessed in the following genetic model: allelic model, homozygote model, Heterozygote model, dominant model, recessive model. Data syntheses were conducted using STATA 12.0.Participants with various types cancers were included.Odds ratio (ORs) and 95% confidence interval (CIs) were calculated to assess the risk of tumor.Seven articles including 7 case-control studies, 7423 cases and 11,049 controls were adopted for meta-analysis. Our result demonstrated that LINC00673 rs11655237 C> T was related to the cancer among all model including allelic model (T vs C: pooled OR = 1.24, 95% CI = 1.16-1.41, P < .001), homozygous model (TT vs CC: pooled OR=1.54, 95% CI = 1.36-1.76, P < .001), heterozygous model (CT vs CC: pooled OR=1.24, 95% CI = 1.16-1.32, P < .001), dominant model (CT + TT vs CC: pooled OR=1.28, 95% CI = 1.20-1.36, P < .001) and recessive model (TT vs CT+ CC: pooled OR=1.42, 95% CI = 1.25-1.61, P < .001). Subgroup analysis also demonstrated that polymorphisms at this site also increased the risk of neuroblastoma.Our results find that rs11655237 contributed to occurrence of cancer in all models in Chinese population.
Supplementary Table 1 from EZH2-Mediated Concordant Repression of Wnt Antagonists Promotes β-Catenin–Dependent Hepatocarcinogenesis

Alfred S.L. Cheng,Suki S. Lau,Yangchao Chen,Yutaka Kondo,May S. Li,Hai Feng,Arthur K. Ching,Kin F. Cheung,Hoi K. Wong,Joanna H. Tong,Hongchuan Jin,Kwong W. Choy,Jun Yu,Ka F. To,Nathalie Wong,Tim H.-M. Huang,Joseph J.Y. Sung

DOI: https://doi.org/10.1158/0008-5472.22395236.v1

2023-01-01

Abstract:Supplementary Table 1 from EZH2-Mediated Concordant Repression of Wnt Antagonists Promotes β-Catenin–Dependent Hepatocarcinogenesis
Supplementary Table 7 from EZH2-Mediated Concordant Repression of Wnt Antagonists Promotes Β-Catenin–dependent Hepatocarcinogenesis

Alfred S.L. Cheng,Suki S. Lau,Yangchao Chen,Yutaka Kondo,May S. Li,Hai Feng,Arthur K. Ching,Kin F. Cheung,Hoi K. Wong,Joanna H. Tong,Hongchuan Jin,Kwong W. Choy,Jun Yu,Ka F. To,Nathalie Wong,Tim H.-M. Huang,Joseph J.Y. Sung

DOI: https://doi.org/10.1158/0008-5472.22395233

2023-01-01

Abstract:Supplementary Table 7 from EZH2-Mediated Concordant Repression of Wnt Antagonists Promotes β-Catenin–Dependent Hepatocarcinogenesis
Supplementary Table 4 from LINC00869 Promotes Hepatocellular Carcinoma Metastasis Via Protrusion Formation

Xiaowen Shao,Yamei Dang,Tingting Zhang,Nan Bai,Jianing Huang,Mengya Guo,Li Sun,Minghe Li,Xiao Sun,Xinran Zhang,Feng Han,Ning Zhang,Hao Zhuang,Yongmei Li

DOI: https://doi.org/10.1158/1541-7786.25325111.v1

2024-01-01

Abstract:Sequences of the DNA primers for RT-qPCR and in vitro transcription, and the sequences of LINC00869 probes.
Supplementary Tables 8 - 9 from LncRNA GClnc1 Promotes Gastric Carcinogenesis and May Act As a Modular Scaffold of WDR5 and KAT2A Complexes to Specify the Histone Modification Pattern

Tian-Tian Sun,Jie He,Qian Liang,Lin-Lin Ren,Ting-Ting Yan,Ta-Chung Yu,Jia-Yin Tang,Yu-Jie Bao,Ye Hu,Yanwei Lin,Danfeng Sun,Ying-Xuan Chen,Jie Hong,Haoyan Chen,Weiping Zou,Jing-Yuan Fang

DOI: https://doi.org/10.1158/2159-8290.22531628.v1

2023-01-01

Abstract:Supplementary Table 8. Sequence of primers for real-time PCR. Supplementary Table 9. Sequence of primers for CHIP real-time PCR.
Supplementary Methods, Figures 1-9, Tables 2-6 from EZH2-Mediated Concordant Repression of Wnt Antagonists Promotes Β-Catenin–dependent Hepatocarcinogenesis

Alfred S.L. Cheng,Suki S. Lau,Yangchao Chen,Yutaka Kondo,May S. Li,Hai Feng,Arthur K. Ching,Kin F. Cheung,Hoi K. Wong,Joanna H. Tong,Hongchuan Jin,Kwong W. Choy,Jun Yu,Ka F. To,Nathalie Wong,Tim H.-M. Huang,Joseph J.Y. Sung

DOI: https://doi.org/10.1158/0008-5472.22395239.v1

2023-01-01

Abstract:Supplementary Methods, Figures 1-9, Tables 2-6 from EZH2-Mediated Concordant Repression of Wnt Antagonists Promotes β-Catenin–Dependent Hepatocarcinogenesis
Supplementary Table 1 from HAb18G/CD147 Promotes Pstat3-Mediated Pancreatic Cancer Development Via CD44s

Ling Li,Wenhua Tang,Xiaoqing Wu,David Karnak,Xiaojie Meng,Rachel Thompson,Xinbao Hao,Yongmin Li,Xiaotan T. Qiao,Jiayuh Lin,James Fuchs,Diane M. Simeone,Zhi-Nan Chen,Theodore S. Lawrence,Liang Xu

DOI: https://doi.org/10.1158/1078-0432.22446368.v1

2023-01-01

Abstract:PDF file - 112K, The sequences of the oligonucleotide primers used for qPCR (related to the qRT-PCR section of Materials and Methods).
An insertion/deletion polymorphism in the 3′ untranslated region of β-transducin repeat-containing protein (βTrCP) is associated with susceptibility for hepatocellular carcinoma in Chinese

Shougong Chen,Yan He,Jun Ding,Yuting Jiang,Shasha Jia,Wei Xia,Ji Zhao,Man Lu,Zhenyong Gu,Yuzhen Gao

DOI: https://doi.org/10.1016/j.bbrc.2009.11.096

IF: 3.1

2010-01-01

Biochemical and Biophysical Research Communications

Abstract:Hepatocellular carcinoma (HCC) is an epithelial cancer which originates from hepatocytes or their progenitors. As a positive regulator of NFκB signaling pathway, β-transducin repeat-containing protein (βTrCP) is overexpressed and oncogenic in epithelial cancers, suggesting a potential role of βTrCP in HCC susceptibility. We carried out a case-control study in a Chinese population (256 cases and 367 controls) to estimate the susceptibility to HCC associated with a 9bp insertion/deletion polymorphism (rs16405) in 3′ untranslated region of βTrCP. Using unconditional logistic regression, we found that 9N del/del and 9N ins/del genotypes were significantly associated with decreased HCC risk: OR=0.44 (0.24–0.83) (p=0.004) and OR=0.56 (0.31–1.00) (p=0.034), respectively. Furthermore, in vivo experiments showed that mRNA levels of βTrCP from HCC tumor tissues were correlated with rs16405 genotypes. HCC tumor tissues with homozygous for 9N ins/ins has the highest level of βTrCP, which are 3.99 and 7.04-fold higher than heterozygous 9N ins/del and homozygous 9N del/del, respectively. Based on bioinformatics prediction, we found that the risk allele for rs16405 disrupted a binding site for human microRNA-920 which would negatively regulate βTrCP. We propose a microRNA-920 mediated βTrCP regulation model depending on rs16405 genotype, which warrants further replication association studies and follow-up functional experiments.
The Association of Rs710886 in Lncrna PCAT1 with Bladder Cancer Risk in a Chinese Population.

Yadi Lin,Yuqiu Ge,Yunyan Wang,Gaoxiang Ma,Xiaowei Wang,Hanting Liu,Meilin Wang,Zhengdong Zhang,Haiyan Chu

DOI: https://doi.org/10.1016/j.gene.2017.06.021

IF: 3.913

2017-01-01

Gene

Abstract:OBJECTIVE:The long noncoding RNA PCAT1 is an important gene involved in urinary tumors. In this study, we aimed to explore the association between polymorphisms in PCAT1 and bladder cancer susceptibility.METHODS:A two-stage case-control study was conducted to assess the association between four tagging SNPs (i.e., rs4871771, rs1902432, rs16901904 and rs710886) and bladder cancer risk. Odds ratios (ORs) and their 95% confidence intervals (CIs) were calculated with unconditional univariate and multivariate logistic regression.RESULTS:At the first stage of discovery, we identified that SNP rs710886A>G was significantly associated with bladder cancer risk (OR=0.86, 95% CI=0.74-0.99, P=0.046). At the following stage of validation, individuals with GG genotype were found to have a significant reduction in bladder cancer risk compared with those carrying AA genotype (adjusted OR=0.83, 95% CI=0.74-0.93, P=0.001). Furthermore, stratified analyses showed that protective effect of rs710886 was more pronounced in subgroup of age>60 and never smoking, and had little to do with sex. Besides, rs710886 was identified as an eQTL for PCAT1. G allele was consistent with lower PCAT1 expression.CONCLUSION:This study indicates that genetic variants in lncRNA PCAT1 were associated with bladder cancer susceptibility and the SNP rs710886 may act as a potential biomarker for bladder cancer risk.
Supplementary Tables 1 - 3 from Reversing Effect of Ring Finger Protein 43 Inhibition on Malignant Phenotypes of Human Hepatocellular Carcinoma

Chunyang Xing,Wuhua Zhou,Songming Ding,Haiyang Xie,Wu Zhang,Zhe Yang,Bajin Wei,Kangjie Chen,Rong Shi,Jiang Cheng,Shusen Zheng,Lin Zhang

DOI: https://doi.org/10.1158/1535-7163.22498585.v1

2023-01-01

Abstract:PDF file - 140K, Primer sequences, Primary antibodies, and Differentially expressed genes after RNF43 knockdown
An Indel Polymorphism Within Pre-Mir3131 Confers Risk for Hepatocellular Carcinoma

Chaoqun Wang,Lijuan Li,Zhixia Yin,Qing Zhang,Hua Zhao,Ruiyang Tao,Shouyu Wang,Shuxiang Hu,Yan He,Dayong Wang,Chengtao Li,Suhua Zhang,Jiejie Xu,Xinghong Jiang,Shaohua Zhu,Yuzhen Gao

DOI: https://doi.org/10.1093/carcin/bgw206

2016-01-01

Carcinogenesis

Abstract:Polymorphisms in pre-miRNAs may affect its expression, then have effect on its target mRNAs and be associated with cancer susceptibility. In this study, we evaluated the association of an indel polymorphism rs57408770 in pre-miR-3131 with hepatocellular carcinoma (HCC) susceptibility in a Chinese population. The contribution of rs57408770 to HCC risk was investigated in two independent case-control sets (1051 HCC and 1058 controls). Logistic regression analysis showed that the insertion allele of rs57408770 was significantly associated with an increased risk for HCC occurrence in both case-control studies. Moreover, the results of genotype-phenotype correlation analysis from both in vivo and in vitro experiments showed that the insertion allele was significantly correlated with higher expression of mature miR-3131 comparing with the deletion allele. The RNA-Binding Protein Immunoprecipitation assay results indicated that rs57408770 could affect the expression level of mature miR-3131 probably through disturbing the binding of splicing factor SRp20 with pre-miR-3131. Furthermore, overexpression of miR-3131 displayed a proliferation promoting and anti-apoptosis effect on HCC cell lines, suggesting that miR-3131 may act as a proto-oncogene in HCC. Finally, human genome-wide gene expression profile assay was used to screen the targets of miR-3131. The overexpressed miR-3131 could lead to a significant decrease of DTHD1 and XAF1 mRNA level. Taken together, our findings provided evidence that rs57408770 may play a functional role in the carcinogenesis of HCC by affecting SRp20 binding with pre-miR-3131 and affecting the expression of mature miR-3131, subsequently affecting the expression of DTHD1 and XAF1, thus confers risk for HCC.
A Functional Insertion/Deletion Polymorphism in the Proximal Promoter Ofcd3gis Associated with Susceptibility for Hepatocellular Carcinoma in Chinese Population

Lingling Jiang,Jingya Xu,Jianqiang Ni,Xueren Gao,Zhansheng Zhu,Dong,Xiaoshu Wang,Chunhua Shi,Xiaoyang Tao,Wanli Dong,Yuzhen Gao

DOI: https://doi.org/10.1089/dna.2012.1706

2012-01-01

DNA and Cell Biology

Abstract:Hepatocellular carcinoma (HCC) represents the most common primary malignancy of the liver with a worldwide increasing incidence. Although the risk factors for HCC are well characterized, the molecular mechanisms responsible for malignant transformation of hepatocytes are not well understood. In this study, a case-control study including 291 HCC patients and 294 healthy controls was conducted to investigate the association between HCC susceptibility and with a 4-bp insertion/deletion polymorphism (rs66465034) in the proximal promoter of CD3G. Logistic regression analysis showed that the heterozygote and the homozygote 4-bp ins/ins confer a significantly increased risk of HCC after controlling for other covariates (adjusted odds ratio [OR]=1.51, 95% confidence interval [C.I.] 1.01-2.27, p=0.040; OR=1.71, 95% C.I. 1.07-2.89, p=0.025, respectively). Carriage of the 4-bp insertion allele was associated with a greatly increased risk of developing the disease (OR=1.30, 95% C.I. 1.02-1.64, p=0.027). Moreover, hepatitis B virus (HBV) stratification analysis showed that the differences between cases and controls were more obvious in HBV-positive than in the HBV-negative population, suggesting a possible role of this polymorphism in the immune regulation during HBV infection. Further, luciferase-based transient transfection assays revealed that rs66465034 can affect promoter activity of CD3G, indicating its possible functional significance. Our data suggested that common genetic polymorphisms in CD3G may influence HCC risk in Chinese population. Considering the relative small sample size, replication in other populations with larger sample size and further functional analysis are required for fully understanding the roles of CD3G polymorphisms in predisposition for HCC.
Supplementary Table 1 from P300 Acetyltransferase Regulates Androgen Receptor Degradation and PTEN-Deficient Prostate Tumorigenesis

Jian Zhong,Liya Ding,Laura R. Bohrer,Yunqian Pan,Ping Liu,Jun Zhang,Thomas J. Sebo,R. Jeffrey Karnes,Donald J. Tindall,Jan van Deursen,Haojie Huang

DOI: https://doi.org/10.1158/0008-5472.22400831.v1

2023-01-01

Abstract:PDF file - 62KB, Primers for genotyping and RT-qPCR.
Supplementary Data 1 from an LTR Retrotransposon-Derived Long Noncoding RNA Lncmer52a Promotes Hepatocellular Carcinoma Progression by Binding P120-Catenin

Yangjun Wu,Yiming Zhao,Lin Huan,Jingjing Zhao,Yuqiang Zhou,Linguo Xu,Zhixiang Hu,Yizhe Liu,Zhiao Chen,Lu Wang,Shenglin Huang,Xianghuo He,Linhui Liang

DOI: https://doi.org/10.1158/0008-5472.22424334.v1

2023-01-01

Abstract:Full scan of all the western blots in the main figures.
An Insertion/Deletion Polymorphism at Mirna-122-Binding Site in the Interleukin-1 Alpha 3' Untranslated Region Confers Risk for Hepatocellular Carcinoma

Yuzhen Gao,Yan He,Jun Ding,Kang Wu,Bo Hu,Yang Liu,Yan Wu,Bingnan Guo,Yueping Shen,Debora Landi,Stefano Landi,Yifeng Zhou,Haiyan Liu

DOI: https://doi.org/10.1093/carcin/bgp283

2009-01-01

Carcinogenesis

Abstract:Hepatocellular carcinoma (HCC) is the fifth most common malignancy caused by environmental and genetic factors. MicroRNAs (miRNAs) are a class of short non-coding RNAs with posttranscriptional regulatory functions. They participate in diverse biological pathways and function as gene regulators. Genetic polymorphisms in 3' untranslated regions (3' UTRs) targeted by miRNAs alter the strength of miRNA binding, with consequences on regulation of target genes thereby affecting the individual's cancer risk. We have previously predicted polymorphisms falling in miRNA-binding regions of cancer genes. We selected an insertion/deletion (Indel) polymorphism (rs3783553) in the 3' UTR of interleukin (IL)-1alpha (IL1A) for a case-control study in a Chinese population. With samples from 403 HCC patients and 434 healthy control individuals, strong evidence of association was observed for the variant homozygote. This association was validated in a second independent case-control study with 1074 HCC patients and 1239 healthy control individuals (odds ratio = 0.62; 95% confidence interval = 0.49-0.78). We further show that the 'TTCA' insertion allele for rs3783553 disrupts a binding site for miR-122 and miR-378, thereby increasing transcription of IL-1alpha in vitro and in vivo. These findings suggest that functional polymorphism rs3783553 in IL1A could contribute to HCC susceptibility. Considering IL-1alpha affects not only various phases of the malignant process, such as carcinogenesis, tumor growth and invasiveness, but also patterns of interactions between malignant cells and the host's immune system, our results indicated that IL-1alpha may be a promising target for immunotherapy, early diagnosis and intervention of HCC.
Supplementary files from An LTR Retrotransposon-Derived Long Noncoding RNA lncMER52A Promotes Hepatocellular Carcinoma Progression by Binding p120-Catenin

Yangjun Wu,Yiming Zhao,Lin Huan,Jingjing Zhao,Yuqiang Zhou,Linguo Xu,Zhixiang Hu,Yizhe Liu,Zhiao Chen,Lu Wang,Shenglin Huang,Xianghuo He,Linhui Liang

DOI: https://doi.org/10.1158/0008-5472.22424325

2023-01-01

Abstract:<p>Supplementary data-The Supplementary information includes: Figure S1. The genomic location, subcellular distribution, full length and coding potential of lncMER52A. Figure S2. The knockdown efficiency and specificity of lncMER52A siRNAs and Crispr-Cas9 mediated knockdown. The effects of lncMER52A on the migration, invasion and metastasis of HCC cells. Figure S3. The correlation of lncMER52A and p120-catenin in HCC tissues and paired normal livers. Figure S4. lncMER52A overexpression significantly inhibited the interaction between β-TrCP1 and p120-catenin. Figure S5. The effects of p120-catenin on the migration and invasion of HCC cells in vitro. Figure S6. H3K4me3 and H3K27ac levels at the promoter of lncMER52A in Huh7 and HepG2-C3A cells. Table S1. Primers for RACE assays. Table S2. Sequence of siRNAs and gRNAs. Table S3. Primers used in molecular cloning of vectors. Table S4. Primers used in the RNA pulldown assays. Table S5. Primers used in the northern blot assays. Table S6. Primers used in the qPCR experiments. Table S7. Primers used in the ChIP assays. Table S8. The correlation of lncMER52A expression with HCC. clinicopathological features.</p>
Supplementary Table S1 from METTL1-Mediated M<sup>7</sup>g Trna Modification Promotes Lenvatinib Resistance in Hepatocellular Carcinoma

Manling Huang,Jianting Long,Zhijia Yao,Yi Zhao,Yutong Zhao,Junbin Liao,Kai Lei,Han Xiao,Zhengde Dai,Sui Peng,Shuibin Lin,Lixia Xu,Ming Kuang

DOI: https://doi.org/10.1158/0008-5472.22433516

2023-01-01

Abstract:This file shows the antibodies used in the study.
Supplementary Table S2 from TMEFF2 Deregulation Contributes to Gastric Carcinogenesis and Indicates Poor Survival Outcome

Tao Sun,Wei Du,Hao Xiong,Yihua Yu,Yiwu Weng,Ren Lang,Huijun Zhao,Yingchao Wang,Yingxuan Chen,Jie Xu,Yong‐Bing Xiang,Wei Qin,Weibiao Cao,Weiping Zou,Haoyan Chen,Hong Ji,Jing‐Yuan Fang

DOI: https://doi.org/10.1158/1078-0432.22456286.v1

2023-01-01

Abstract:Supplementary Table S2. Sequence of primers for real-time PCR.

Supplementary Table 1 from An Insertion/Deletion Polymorphism within RERT-lncRNA Modulates Hepatocellular Carcinoma Risk

Supplementary Figure 2 from An Insertion/Deletion Polymorphism within RERT-lncRNA Modulates Hepatocellular Carcinoma Risk

Association Between the LINC00673 Rs11655237 C&gt; T Polymorphisms with Cancer Risk in the Chinese Population: A Meta-Analysis

Supplementary Table 1 from EZH2-Mediated Concordant Repression of Wnt Antagonists Promotes β-Catenin–Dependent Hepatocarcinogenesis

Supplementary Table 7 from EZH2-Mediated Concordant Repression of Wnt Antagonists Promotes Β-Catenin–dependent Hepatocarcinogenesis

Supplementary Table 4 from LINC00869 Promotes Hepatocellular Carcinoma Metastasis Via Protrusion Formation

Supplementary Tables 8 - 9 from LncRNA GClnc1 Promotes Gastric Carcinogenesis and May Act As a Modular Scaffold of WDR5 and KAT2A Complexes to Specify the Histone Modification Pattern

Supplementary Methods, Figures 1-9, Tables 2-6 from EZH2-Mediated Concordant Repression of Wnt Antagonists Promotes Β-Catenin–dependent Hepatocarcinogenesis

Supplementary Table 1 from HAb18G/CD147 Promotes Pstat3-Mediated Pancreatic Cancer Development Via CD44s

An insertion/deletion polymorphism in the 3′ untranslated region of β-transducin repeat-containing protein (βTrCP) is associated with susceptibility for hepatocellular carcinoma in Chinese

The Association of Rs710886 in Lncrna PCAT1 with Bladder Cancer Risk in a Chinese Population.

Supplementary Tables 1 - 3 from Reversing Effect of Ring Finger Protein 43 Inhibition on Malignant Phenotypes of Human Hepatocellular Carcinoma

An Indel Polymorphism Within Pre-Mir3131 Confers Risk for Hepatocellular Carcinoma

A Functional Insertion/Deletion Polymorphism in the Proximal Promoter Ofcd3gis Associated with Susceptibility for Hepatocellular Carcinoma in Chinese Population

Supplementary Table 1 from P300 Acetyltransferase Regulates Androgen Receptor Degradation and PTEN-Deficient Prostate Tumorigenesis

Supplementary Data 1 from an LTR Retrotransposon-Derived Long Noncoding RNA Lncmer52a Promotes Hepatocellular Carcinoma Progression by Binding P120-Catenin

An Insertion/Deletion Polymorphism at Mirna-122-Binding Site in the Interleukin-1 Alpha 3' Untranslated Region Confers Risk for Hepatocellular Carcinoma

Supplementary files from An LTR Retrotransposon-Derived Long Noncoding RNA lncMER52A Promotes Hepatocellular Carcinoma Progression by Binding p120-Catenin

Supplementary Table S1 from METTL1-Mediated M&lt;sup&gt;7&lt;/sup&gt;g Trna Modification Promotes Lenvatinib Resistance in Hepatocellular Carcinoma

Supplementary Table S2 from TMEFF2 Deregulation Contributes to Gastric Carcinogenesis and Indicates Poor Survival Outcome

Association Between the LINC00673 Rs11655237 C> T Polymorphisms with Cancer Risk in the Chinese Population: A Meta-Analysis

Supplementary Table S1 from METTL1-Mediated M<sup>7</sup>g Trna Modification Promotes Lenvatinib Resistance in Hepatocellular Carcinoma